Shingrix Revaccination and Vaccination in Vulnerable Populations

Authors

Laressa Bethishou, Chapman UniversityFollow
Luma Munjy, Chapman University
John Andraos, Chapman University

Document Type

Article

Publication Date

3-17-2019

Abstract

"Herpes zoster, also known as shingles, is a painful cutaneous eruption that develops following the reactivation of the varicella zoster virus (VZV), the same virus that causes chickenpox.¹ About 1 in 3 people in the United States will develop shingles, with an estimated 1 million cases occurring annually. Anyone with a history of chickenpox is at risk for shingles, but the risk increases with age and in patients who are immunocompromised.²"

Comments

This article was originally published in Pharmacy Times in 2019.

Recommended Citation

Bethishou L, Munjy L, Andraos J. Shingrix revaccination and vaccination in vulnerable populations. Pharmacy Times. https://www.pharmacytimes.com/publications/supplements/2019/march2019/shingrix-revaccination-and-vaccination-in-vulnerable-populations. Published March 17, 2019.

Copyright

Pharmacy Times